FdaApplication
ANDA 210596
Identifiers
- fda_app_no: ANDA210596
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2022-09-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VYDUO | NEBIVOLOL HYDROCHLORIDE; VALSARTAN | EQ 5MG BASE;80MG | TABLET;ORAL |
1 product